SNRIs - Serotonin-Norepinephrine reuptake inhibitors
🌊 SNRIs – Serotonin–Norepinephrine Reuptake Inhibitors
What they are:
SNRIs are antidepressants that increase two brain chemicals: serotonin and norepinephrine. They can help with anxiety, depression, and certain pain conditions.
Common examples:
• Duloxetine (Cymbalta)
• Venlafaxine (Effexor)
Uses in kids and teens 🧠
• Duloxetine is FDA-approved for Generalized Anxiety Disorder (GAD) in children 7–17 years old.
• Sometimes used (off-label) for depression or chronic pain when other medications aren’t enough.
How they work:
SNRIs block the “reuptake pumps” for serotonin and norepinephrine, helping nerve cells communicate more steadily. Norepinephrine is tied to alertness, focus, and the body’s stress response – boosting it slightly can improve energy and concentration.
Stats & facts 📊
• In U.S. adolescents, antidepressant use (mostly SSRIs, some SNRIs) sits around 4–5%, and SSRIs are usually tried first.
• Evidence shows duloxetine improves anxiety scores more than placebo in youth with GAD.
Common side effects:
• Nausea, dry mouth
• Sleep changes (tiredness or insomnia)
• Headaches
• Increased sweating
• Sometimes a temporary increase in anxiety in the first weeks
Safety notes for families ⚠️
• Like SSRIs, SNRIs carry the suicidality black-box warning in people under 25. Families should watch for new agitation, dark thoughts, or behavior changes and contact the prescriber right away.
• SNRIs can raise blood pressure or heart rate in some people, so doctors may check vitals regularly.
References (SNRIs):
• Dwyer, J. B., et al. (2019). Antidepressants for pediatric patients. Child and Adolescent Psychiatric Clinics.
• U.S. FDA. (2020). CYMBALTA (duloxetine) label – Pediatric GAD indication.